EMEA-001739-PIP02-16

Key facts

Active substance
  • ketamine (hydrochloride)
  • sufentanil citrate
Therapeutic area
Pain
Decision number
P/0413/2019
PIP number
EMEA-001739-PIP02-16
Pharmaceutical form(s)
Nasal spray, solution
Condition(s) / indication(s)
Treatment of acute pain
Route(s) of administration
Intranasal use
Contact for public enquiries
Copenhagen University Hospital, Rigshospitalet

E-mail: bettina.nygaard.nielsen@regionh.dk
Tel.  +45 35459546

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating